Washington — NIOSH is asking for stakeholder comment on three draft documents pertaining to hazardous drugs in health care settings.
According to a notice published in the May 1 Federal Register, the documents are “Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings”; “Managing Hazardous Drug Exposures: Information for Healthcare Settings”; and “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020.”
The agency is asking users of the list to name the unique ingredient identifier they find most useful. It adds that because of conflicting evidence on the hazard posed by botulinum toxins to workers who handle these drugs, NIOSH is not proposing to place the toxins on the list at this time. The agency invites additional studies, data and expert opinions pertinent to this issue to evaluate botulinum toxins more fully.
Comments are due June 30.
